首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Twenty-two years of candidaemia surveillance: results from a Norwegian national study
【24h】

Twenty-two years of candidaemia surveillance: results from a Norwegian national study

机译:22年念珠菌病监测:挪威一项全国性研究的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Several studies have reported an increased incidence of candidaemia and a redistribution of species, with a decrease in the number of Candida albicans isolates. In Norway, a prospective, national surveillance study of candidaemia has been ongoing since 1991. Data from the period 1991-2003 have been published previously. The aim of this study was to follow up the incidence, species distribution and antifungal susceptibility of Candida species isolates from blood cultures in the period 2004-2012, and compare them with the corresponding findings from the period 1991-2003. Blood culture isolates of Candida species from all medical microbiological laboratories in Norway were identified and susceptibility tested at the Norwegian Mycological Reference Laboratory. A total of 1724 isolates were recovered from 1653 patients in the period 2004-2012. Comparison of the two periods showed that the average incidence of candidaemia episodes per 100 000 inhabitants increased from 2.4 (1991-2003) to 3.9 (2004-2012). The increase in incidence in the latter period was significantly higher in patients aged >40 years (p 0.001), and a marked increase was observed in patients aged >60 years (p < 0.001). In conclusion, the average incidence in Norway over a period of 22 years modestly increased from 2.4 to 3.9 per 100 000 inhabitants, this being mainly accounted for by candidaemia in the elderly. The species distribution was stable, and the rate of acquired resistance was low. Clinical Microbiology and Infection (C) 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
机译:几项研究报告了念珠菌血症的发病率增加,物种重新分布,白色念珠菌分离株的数量减少。在挪威,自1991年以来就一直在进行关于念珠菌血症的前瞻性全国监测研究。1991-2003年期间的数据先前已经发表。这项研究的目的是跟踪2004-2012年期间血液培养中念珠菌分离株的发生率,种类分布和抗真菌药性,并将其与1991-2003年期间的相应发现进行比较。鉴定了挪威所有医学微生物实验室的念珠菌属血培养分离物,并在挪威真菌学参考实验室检测了药敏性。在2004-2012年期间,共从1653名患者中回收了1724株分离株。这两个时期的比较表明,每10万居民中念珠菌血症发作的平均发生率从2.4(1991-2003)增加到3.9(2004-2012)。大于40岁的患者在后期的发病率增加显着更高(p 0.001),大于60岁的患者则显着增加(p <0.001)。总之,挪威在22年内的平均发病率从每10万人中2.4上升到3.9,这主要是由老年人念珠菌血症引起的。物种分布稳定,获得的抗性率低。临床微生物学和感染(C)2015年欧洲临床微生物学和传染病学会。由Elsevier Ltd.出版。保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号